Protagonist Therapeutics, Inc. (PTGX) Social Stream



Protagonist Therapeutics, Inc. (PTGX): $8.07

-0.38 (-4.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Protagonist Therapeutics Inc (PTGX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PTGX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 7 $93 $40 $56.857 $24.91 128.25%
2021-11-15 7 $93 $40 $58.285 $24.91 133.98%
2022-01-27 7 $93 $40 $59 $24.91 136.85%
2022-03-02 8 $93 $40 $58.5 $24.91 134.85%
2022-03-24 8 $93 $40 $58 $24.91 132.84%

The Trend in the Analyst Price Target


Over the past 41 days, PTGX's average price target has gone down $0.5.

PTGX reports an average of 96.11% for its upside potential over the past 140 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-03 7 93 40 59.0 35.32 67.04%
2022-03-01 8 93 40 58.5 26.25 122.86%
2022-03-02 8 93 40 58.5 26.58 120.09%
2022-03-02 8 93 40 58.0 26.58 118.21%
2022-03-24 8 93 40 58.0 25.17 130.43%

PTGX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


Over the past 151 days, PTGX's average broker recommendation rating improved by 0.88.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Protagonist Therapeutics Inc's variance in analysts' estimates is lower than -439.31% of them.
  • To contextualize these metrics, consider that out of all US stocks, Protagonist Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 499.14% of them.
  • In terms of how Protagonist Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 445.24% of that group.
  • In the context of Pharmaceutical Products stocks, Protagonist Therapeutics Inc's number of analysts covering the stock is greater than 386.97% of them.

Stocks similar to Protagonist Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTCT, PRTA, and PRLD.

Is PTGX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4248 seconds.